The Use of Localised Vaginal Drug Delivery as Part of a Neoadjuvant Chemotherapy Strategy in the Treatment of Cervical Cancer
DOI:
https://doi.org/10.17140/GOROJ-2-106Abstract
Cervical cancer is the third most prevalent cancer in women globally, with 529,000 diagnosis and 275,000 deaths each year. It is especially prevalent in developing countries where approximately 85% of cases arise due to the lack of cervical cancer prevention and control programs. In developed countries, where women have access to resources capable of detecting and treating precancerous lesions, the number of cases is reduced by approximately 80%.
References
de Freitas AC, Gurgel AP, Chagas BS, Coimbra EC, do Amaral CM. Susceptibility to cervical cancer: an overview. Gynecol On-col. 2012; 126(2): 304-311. doi: 10.1016/j.ygyno.2012.03.047
Sharma R. HPV vaccine: A breakthrough in prevention of cer-vical cancer. Apollo Medicine. 2012; 9(2): 87-90. doi: 10.1016/j. apme.2012.05.005
Denny L. Cytological screening for cervical cancer preven-tion. Best Pract Res Clin Obstet Gynaecol. 2012; 26(2): 189- 196. doi: 10.1016/j.bpobgyn.2011.08.001
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wa-cholder S. Human papillomavirus and cervical cancer. Lancet. 2007; 370(s): 890-907. doi: 10.1016/S0140-6736(07)61416-0
Chien LN, Adams EK, Flowers LC. Treating cervical cancer: breast and cervical cancer prevention and treatment act patients. Am J Obstet Gynecol. 2011; 204(6): 533-533. doi: 10.1016/j. ajog.2011.01.033
Covens A, Rosen B, Murphy J, et al. Changes in the Demo-graphics and perioperative care of stage Ia(2)/Ib(1) cervical can-cer over the past 16 years. Gynecol Oncol. 2001; 81(2): 133-137. doi: 10.1006/gyno.2001.6158
Rob L, Skapa P, Robova H. Fertility-sparing surgery in pa-tients with cervical cancer. Lancet Oncol. 2011; 12(2):192-200. doi: 10.1016/S1470-2045(10)70084-X
Roy M, Plante M. Pregnancies after radical vaginal trachelec-tomy for early stage cervical cancer. Am J Obstet Gynecol. 1998; 179(6 Pt 1):1491-1496. doi: 10.1016/S0002-9378(98)70014-6
Mathevet P, Laszlo de Kaszon E, Dargent D. Fertility pres-ervation in early cervical cancer. Gynecol Obstet Fertil. 2003; 31(9): 706-712. doi: 10.1016/S1297-9589(03)00200-5
Plante M, Renaud MC, François H, Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. an update series of 72 cases and review of the literature. Gynecol Oncol. 2004; 94(3):614-623. doi: 10.1016/j.ygyno.2004.05.032
Nishio H, Fujii T, Kameyama K, et al. Abdominal radical trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer in a series of 61 women. Gynecol Oncol. 2009; 115(1): 51-55. doi: 10.1016/j.ygyno.2009.06.036
Robova H, Halaska M, Pluta M, et al. The role of neoad-juvant chemotherapy and surgery in cervical cancer. Int J Gy-necol Cancer. 2010; 20(11 Suppl 2): S42-S46. doi: 10.1111/ IGC.0b013e3181f60d73
Robova H, Rob L, Halaska MJ, et al. High-dose density neoadjuvant chemotherapy in bulky IB cervical cancer. Gynecol Oncol. 2013; 128(1):49-53. doi: 10.1016/j.ygyno.2012.10.002
Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cellcervical cancer: result from the Italian multicentre randomized study. J Clin Oncol. 2002; 20(1):179-188. doi: 10.1200/JCO.20.1.179
Rydzewska L, Tierney J, Vale CL, Symonds PR. Neoadju-vant chemotherapy plus surgery versus surgery for cervical can-cer (Review). Cochrane Database. 2012; 12: CD007406. doi: 10.1002/14651858.CD007406.pub3
Wolinsky JB, Colson YL, Grinstaff MW. Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers. J Con Rel. 2012; 159(1):14-26. doi: 10.1016/j.jconrel.2011.11.031
Friend D. Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually trans-mitted infections. Drug Deliv Transl Res. 2011; 1(3): 185-193. doi: 10.1007/s13346-011-0024-4
Loxley A, Mitchnick M, Okoh O, et al. Ethylene vinyl acetate intravaginal rings for the simultaneous delivery of the antiretro-viral uc781 and contraceptive levonorgestrel. Drug Deliv Transl Res. 2011; 1(3): 247-255. doi: 10.1007/s13346-011-0031-5
Malcolm RK, Woolfson AD, Toner CF, Morrow RJ, McCul-lagh SD. Long-term, controlled release of the hiv microbicide Gynecol Obstet Res Open J tmc120 from silicone elastomer vaginal rings. J Antimicrob Chemother. 2005; 56(5): 954-956. doi: 10.1093/jac/dki326
McConville C, Major I, Friend DR, Clark MR, Malcolm RM. Development of a UC781 releasing poly ethylene vinyl ac-etate vaginal ring. Drug Deliv Transl Res. 2012; 2(6): 489-497. doi: 10.1007/s13346-012-0101-3
McConville C, Friend DR, Clark MR, Malcolm K. Prefor-mulation and development of a once-daily sustained-release ten-ofovir vaginal tablet containing a single excipient. J Pharm Sci. 2013; 102(6): 1859-1866. doi: 10.1002/jps.23528
Malcolm RM, Forbes CJ, Geer L, et al. Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques. J Antimicrob Chemother. 2013; 68(3): 678-683. doi: 10.1093/jac/dks422
Karim AQ, Karim SSA, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the pre-vention of HIV infection in women. Science. 2010; 329(5996): 1168-1174. doi: 10.1126/science.1193748
Woolfson AD, McCafferty DF, McCarron PA, Price JH. A bioadhesive patch cervical drug delivery system for the admin-istration of 5-fluorouracil to cervical tissue. J Con Rel. 1995; 35(1): 49-58. doi: 10.1016/0168-3659(95)00018-4
Graham V, Surwit ES, Weiner S, Meyskens FL. Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neopla-sia delivered via a collagen sponge and cervical cap. West J Med. 1986; 145(2); 192-195.
Kirwan P, Naftalin NJ. Topical 5-fluorouracil in the treat-ment of vaginal intraepithelial neoplasia. Br J Obstet Gynaecol. 1985; 92(3): 287-291.
Keskar V, Mohanty PS, Gemeinhart EJ, Gemeinhart RA. Cervical cancer treatment with a locally insertable controlled release delivery system. J Con Rel. 2006; 115(3): 280-288. doi: 10.1016/j.jconrel.2006.08.014
Hodge LS, Downs LS, Chura LC, et al. Localized delivery of chemotherapy to the cervix for radiosensitization. Gynecol On-col. 2012; 127(1): 121-125. doi: 10.1016/j.ygyno.2012.07.097
Boyd P, Major I, Wang W, McConville C. Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer. Eur J Pharm Biopharm. 2014; 88(3): 945-953. doi: 10.1016/j.ejpb.2014.08.002
Baffoe CS, Nguyen N, Boyd P, Wang W, Morris M, McCon-ville C. Disulfiram-loaded immediate and extended release vagi-nal tablets for the localised treatment of cervical cancer. J Pharm Pharmacol. 2015; 67(2):189-198. doi: 10.1111/jphp.12330
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Gynecology and Obstetrics Research (GOR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
